Incidence of cardiovascular diseases and type-2-diabetes mellitus in patients with psychiatric disorders

References

• Kessler RC, Aguilar-Gaxiola S, Alonso J, et al. The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psichiatr Soc. 2009;18(1):23–33.
   PubMed Web of Science ®Google Scholar
• Steel Z, Marnane C, Iranpour C, et al. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980–2013. Int J Epidemiol. 2014;43:476–493.
   PubMed Web of Science ®Google Scholar
• Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J. 2006;27:2763–2774.
   PubMed Web of Science ®Google Scholar
• Arroyo C, Hu FB, Ryan LM, et al. Depressive symptoms and risk of type 2 diabetes in women. Diabetes Care. 2004;27:129–133.
   PubMed Web of Science ®Google Scholar
• De Hert M, Dekker JM, Wood D, et al. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry. 2009;24:412–424.
   PubMed Web of Science ®Google Scholar
• Golden SH, Williams JE, Ford DE, et al. Depressive symptoms and the risk of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes Care. 2004;27:429–435.
   PubMed Web of Science ®Google Scholar
• Henderson DC, Vincenzi B, Andrea NV, et al. Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses. Lancet Psychiatry. 2015;2:452–464.
   PubMed Web of Science ®Google Scholar
• Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005;19:1–93.
   PubMed Web of Science ®Google Scholar
• Stahl SM, Mignon L, Meyer JM. Which comes first: atypical antipsychotic treatment or cardiometabolic risk? Acta Psychiatr Scand. 2009;119:171–179.
   PubMed Web of Science ®Google Scholar
• Bresee LC, Majumdar SR, Patten SB, et al. Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study. Schizophr Res. 2010;117:75–82.
   PubMed Web of Science ®Google Scholar
• Chien IC, Chang KC, Lin CH, et al. Prevalence of diabetes in patients with bipolar disorder in Taiwan: a population-based national health insurance study. Gen Hosp Psychiatry. 2010;32:577–582.
   PubMed Web of Science ®Google Scholar
• Chien IC, Hsu JH, Lin CH, et al. Prevalence of diabetes in patients with schizophrenia in Taiwan: a population-based National Health Insurance study. Schizophr Res. 2009;111:17–22.
   PubMed Web of Science ®Google Scholar
• de Groot M, Anderson R, Freedland KE, et al. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001;63:619–630.
   PubMed Web of Science ®Google Scholar
• De Hert M, van Winkel R, Van Eyck D, et al. Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study. Clin Pract Epidemiol Ment Health. 2006;2:14.
   PubMedGoogle Scholar
• McIntyre RS, Konarski JZ, Misener VL, et al. Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications. Ann Clin Psychiatry. 2005;17:83–93.
   PubMedGoogle Scholar
• van Winkel R, De Hert M, Van Eyck D, et al. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. Bipolar Disord. 2008;10:342–348.
   PubMed Web of Science ®Google Scholar
• Le Noury J, Khan A, Harris M, et al. The incidence and prevalence of diabetes in patients with serious mental illness in North West Wales: two cohorts, 1875–1924 & 1994–2006 compared. BMC Psychiatry. 2008;8:67.
   PubMed Web of Science ®Google Scholar
• Ramsey CM, Leoutsakos JM, Mayer LS, et al. History of manic and hypomanic episodes and risk of incident cardiovascular disease: 11.5 year follow-up from the Baltimore Epidemiologic Catchment Area Study. J Affect Disord. 2010;125:35–41.
   PubMed Web of Science ®Google Scholar
• Yood MU, DeLorenze G, Quesenberry CP Jr, et al. The incidence of diabetes in atypical antipsychotic users differs according to agent – results from a multisite epidemiologic study. Pharmacoepidem Drug Safe. 2009;18:791–799.
   PubMed Web of Science ®Google Scholar
• Martinell M, Stalhammar J, Hallqvist J. Automated data extraction – a feasible way to construct patient registers of primary care utilization. Ups J Med Sci. 2012;117:52–56.
   PubMed Web of Science ®Google Scholar
• Ringborg A, Lindgren P, Martinell M, et al. Prevalence and incidence of type 2 diabetes and its complications 1996–2003 – estimates from a Swedish population-based study. Diabet Med. 2008;25:1178–1186.
   PubMed Web of Science ®Google Scholar
• Gothefors D, Adolfsson R, Attvall S, et al. Swedish clinical guidelines – prevention and management of metabolic risk in patients with severe psychiatric disorders. Nord J Psychiatry. 2010;64:294–302.
   PubMed Web of Science ®Google Scholar
• Pillinger T, Beck K, Gobjila C, et al. Impaired glucose homeostasis in first-episode schizophrenia: a systematic review and meta-analysis. JAMA Psychiatry. 2017;74:261–269.
   PubMed Web of Science ®Google Scholar
• Mangurian C, Newcomer JW, Modlin C, et al. Diabetes and cardiovascular care among people with severe mental illness: a literature review. J Gen Intern Med. 2016;31:1083–1091.
   PubMed Web of Science ®Google Scholar
• Fleischhacker WW, Cetkovich-Bakmas M, De Hert M, et al. Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges. J Clin Psychiatry. 2008;69:514–519.
   PubMed Web of Science ®Google Scholar
• Ekholm B, Ekholm A, Adolfsson R, et al. Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses. Nord J Psychiatry. 2005;59:457–464.
   PubMed Web of Science ®Google Scholar
• Sellgren C, Landen M, Lichtenstein P, et al. Validity of bipolar disorder hospital discharge diagnoses: file review and multiple register linkage in Sweden. Acta Psychiatr Scand. 2011;124:447–453.
   PubMed Web of Science ®Google Scholar
• Holt RI. The prevention of diabetes and cardiovascular disease in people with schizophrenia. Acta Psychiatr Scand. 2015;132:86–96.
   PubMed Web of Science ®Google Scholar